EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Identification of Potential Drug-Drug Interactions in the Pediatric Intensive Care Unit of a Tertiary Care Teaching Hospital of Odisha, India

Paramita Parida, Sagar Parida, Debasish Misra, Debasmita Rath

Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ) · 01.04.2026 · 10 (2) · 1-5

DOI: 10.54133/ajms.v10i2.2797 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ), online erschienen am 01.04.2026. Verfasst von Paramita Parida und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To accomplish a specific therapeutic purpose, drugs are frequently used in combination. Concurrent drug use can result in drug-drug interactions (DDIs), which can have negative effects on patients. Information about potential drug-drug interactions (PDDIs) should be made available to healthcare providers. The article reviews our hospital's drug interaction (DI) trend and examines whether it is related to polypharmacy. It also assess the degree of seriousness of potential drug-drug interactions (PDDI).

Objective

To evaluate our hospital's drug-drug interaction trend.

Methods

In this cross-sectional observational study, we examined the prescriptions of children between the ages of one month and fifteen years who were admitted to the PICU. Using drug interaction checking software, we classified the prescriptions according to the severity (Unknown, minor, moderate, and major), the number of concurrent medications used, and the possible consequences of these PDDIs.

Results

We discovered 482 PDDIs out of 101 prescriptions, of which 64.9% were moderate, 19.29% were minor, 12.4% were unknown, and 7.67% were major. The average number of PDDIs per prescription was highest for prescriptions including more than 10 drugs (7.8). Third-generation cephalosporins, ureidopenicillin, carbapenem, and aminoglycosides accounted for 39% of PDDIs, followed by salbutamol (20.12%) and antiepileptic medications (18.67%). Low potassium (11.2%) was the most common possible consequence.

Conclusions

The findings of this study may help with the planning and execution of future research as well as the monitoring and prevention of PDDIs associated with adverse events in children in critical care.

Zitieren

APA

Parida, P., Parida, S., Misra, D., & Rath, D. (2026). Identification of Potential Drug-Drug Interactions in the Pediatric Intensive Care Unit of a Tertiary Care Teaching Hospital of Odisha, India. Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ), 10(2), 1-5. https://doi.org/10.54133/ajms.v10i2.2797

Vancouver

Parida P, Parida S, Misra D, Rath D. Identification of Potential Drug-Drug Interactions in the Pediatric Intensive Care Unit of a Tertiary Care Teaching Hospital of Odisha, India. Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ). 2026;10(2):1-5. doi:10.54133/ajms.v10i2.2797

BibTeX
@article{Parida2026,
  author = {Parida, Paramita and Parida, Sagar and Misra, Debasish and Rath, Debasmita},
  title = {Identification of Potential Drug-Drug Interactions in the Pediatric Intensive Care Unit of a Tertiary Care Teaching Hospital of Odisha, India},
  journal = {Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 )},
  year = {2026},
  volume = {10},
  number = {2},
  pages = {1--5},
  doi = {10.54133/ajms.v10i2.2797}
}
Kostenlos starten →